Unresectable Basal Cell Carcinoma
3 clinical trials · Condition
◉ Watch Unresectable Basal Cell Carcinoma
| Record | Firm | Date |
|---|---|---|
| Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial (NCT07576725) | Fred Hutchinson Cancer Center | 2026-09-01 |
| Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer (NCT05896839) | National Cancer Institute (NCI) | 2024-07-24 |
| Tacrolimus, Nivolumab, and Ipilimumab in Treating Kidney Transplant Recipients With Selected Unresectable or Metastatic Cancers (NCT03816332) | National Cancer Institute (NCI) | 2019-11-08 |
Track Unresectable Basal Cell Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.